Abstract
Background There are known delays to diagnosis for diseases which commonly present with chronic breathlessness, but the subsequent impact is unknown. For adults presenting with breathlessness, we investigated the time taken to achieve an explanatory diagnosis, and associations with unplanned hospitalisation and mortality.
Methods A retrospective cohort study using the UK CPRD was conducted involving adults with a first-recorded code for breathlessness and no pre-existing cardiorespiratory disease. We documented whether an explanatory diagnosis was recorded after the first code of breathlessness within two years and during all follow-up, and the time to diagnosis. Cox regression (adjusted) was used to investigate the associations with unplanned hospitalisation and mortality.
Results 101369 adults were included with a first-recorded code for breathlessness. After two-years, 43394 (43%) adults received a recorded explanatory diagnosis and had a higher risk of unplanned hospitalisation (1.25 [1.19-1.31]) and mortality (2.06 [1.60-2.65]) compared to adults without a diagnosis. Overall, 66909 (66%) adults received a recorded diagnosis during a median of 5-years follow-up. Adults that received a recorded diagnosis after ≥6 months had worse outcomes of unplanned hospitalisation (6-24 months: 1.01 [0.94-1.08]; ≥24 months: 1.13 [1.06-1.20]) and mortality (6-24 months: 3.38 [2.21-5.18]; ≥24 months: 10.80 [7.46-15.70]).
Conclusion We describe a sub-group of adults coded for breathlessness but without an explanatory diagnosis with better outcomes. However, in adults with an explanatory diagnosis waiting beyond six months was associated with worse outcomes. Diagnostic pathways for chronic breathlessness need to differentiate between these two groups and achieve earlier diagnosis in those at higher risk.
What is already known on this topic?
< Delays to diagnosis exist for chronic cardiorespiratory diseases, but the impact of these delays on future hospitalisation and mortality risk are unknown.
What this study adds
< Over a median follow-up of 5 years, 1 in 2 people with breathlessness had an unplanned hospital admission and 11% died.
< We identify a group of patients with a breathlessness code who did not receive a diagnosis but overall had better outcomes than those with an explanatory diagnosis.
< We also report novel findings that for adults who receive an explanatory diagnosis for breathlessness, waiting beyond six months to receive a diagnosis is associated with an increased risk of future unplanned hospital admission and all-cause mortality.
How this study might affect research, practice or policy
< Further research is needed to prioritise investigations early for patients presenting with chronic breathlessness with increased risk of underlying cardiorespiratory disease.
< Diagnostic breathlessness pathways may improve the time to diagnosis and therefore improve longer term outcomes.
< Where an underlying causative diagnosis of cardiorespiratory disease is not identified, outcomes appear better, and attention can be focused on reassurance and symptom management.
Competing Interest Statement
KK is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre (BRC).
Funding Statement
UK is funded by a National Institute for Health Research (NIHR) Biomedical Research Council (BRC) / Leicester Precision Medicine Institute (LPMI) Studentship. RAE is funded by a NIHR Clinician Scientist Fellowship CS-2016-16-020. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Independent Scientific Advisory Committee for Medicines and Healthcare products Regulatory Agency database research (Protocol Number = 20_075). This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Take home message: Time to diagnosis for #breathlessness matters! We found waiting over six months for a diagnosis after presenting with breathlessness was associated with hospital admissions and worse survival. Investigate early for better outcomes!
Data Availability
The study uses data from the Clinical Practice Research Datalink (CPRD). CPRD does not allow the sharing of patient-level data.